Results 101 to 110 of about 6,924 (289)

Cardiovascular disease incidence and cancer risk in two large European prospective cohorts

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Cardiovascular disease (CVD) and cancer share risk factors and biological mechanisms, raising questions about potential associations between the two, particularly regarding CVD duration and cancer onset. Whether CVD influences subsequent cancer risk, however, remains inconclusive.
Emma Fontvieille   +25 more
wiley   +1 more source

The quality of life of disease-free Brazilian breast cancer survivors

open access: yesRevista da Escola de Enfermagem da USP
The objective of this study was to compare the quality of life of women who survived breast cancer and women who have not had the disease, and to identify associated factors. It is cross-sectional study in which the comparison group includes survivors of
Priscila Bernardina Miranda Soares   +6 more
doaj  

Availability of Cancer Screening Across HIV Treatment Sites in the IeDEA Consortium

open access: yesInternational Journal of Cancer, EarlyView.
In recent years, incorporating comprehensive cancer screening strategies into routine HIV care has gained growing attention. This survey of 220 sites providing HIV care across 41 countries shows that cervical cancer screening has increased in availability over time.
Rachael A. Pellegrino   +32 more
wiley   +1 more source

Central Line-Associated Bloodstream Infection Prevention in the Long-Term Acute Care Setting

open access: yes, 2012
Sustained reduction of central line-associated bloodstream infections remains elusive in many institutions, including the long-term acute care hospital (LTACH), despite a focus on improving patient outcomes.
Dougherty, Mary Lisbeth, MSN RN AOCNA
core  

Tumor Infiltrating Lymphocyte Therapy Combined With PD‐1/LAG‐3 Inhibition in Patients With Recurrent Platinum‐Resistant Ovarian Cancer

open access: yesInternational Journal of Cancer, EarlyView.
The detection of tumor‐infiltrating lymphocytes (TILs) is a positive prognostic factor in ovarian cancer. Moreover, TILs are significantly boosted by immunotherapy, though ovarian cancer patients have seen limited benefit from immune therapies. This study investigated the safety and feasibility of TIL therapy combined with PD‐1 and LAG‐3 inhibitors in ...
Tine J. Monberg   +9 more
wiley   +1 more source

Effectiveness of Organized Strategies to Enhance Access to Preventive Oral Cancer Screening Among High‐Risk Individuals in Brazil: A Randomized Clinical Trial in Primary Care

open access: yesInternational Journal of Cancer, EarlyView.
This randomized clinical trial evaluated the performance of organized risk‐based strategies to expand access to cancer preventive oral examination among vulnerable populations within the public health system of Rio de Janeiro, Brazil. Compared with an opportunistic approach, the organized invitation‐based oral cancer screening approaches systematically
Marcia Frias Pinto Marinho   +8 more
wiley   +1 more source

Advancing Oncologic Emergency Preparedness: A Clinical Simulation Approach for Advanced Practice Providers in Oncology

open access: yes
DNP projectIntroduction/Purpose: Orienting advanced practice providers (APPs) in oncology is challenged by the intricate subspecialty knowledge required and limited exposure to high-stakes clinical scenarios during onboarding.
Hemstetter, Sarah
core  

Migration‐Associated Variation in Gastric Cancer Risk in the United States: Implications for Risk Stratification

open access: yesInternational Journal of Cancer, EarlyView.
This study provides contemporary, population‐based evidence that migration‐associated differences in gastric cancer risk, first described decades ago, remain stable, quantifiable, and prevention‐relevant in the United States. By integrating modern cancer registry data with formal trend analysis and conditional extrapolation, the authors show that ...
Chul S. Hyun   +4 more
wiley   +1 more source

Visual nursing

open access: yes, 2019
Includes bibliographical references and index.For an image-rich guide to the clinical concepts and on-the-unit skills needed to treat the major common diseases, look no further than the fully updated Lippincott Visual Nursing, 3rd Edition.
Kantor Debra
core  

Plasma PlGF as a Potential Biomarker in Ramucirumab‐Based Second‐Line Therapy for Advanced Gastroesophageal Adenocarcinoma: Exploratory Biomarker Analysis from the Phase II Part of the RAMIRIS Trial

open access: yesInternational Journal of Cancer, EarlyView.
Antiangiogenic treatment with ramucirumab is a standard second‐line option in advanced gastric and gastroesophageal junction adenocarcinoma. However, reliable biomarkers are currently lacking. This exploratory biomarker analysis of the RAMIRIS trial suggests that elevated baseline and early on‐treatment levels of the pro‐angiogenic placental growth ...
Jurek Hille   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy